Vaccines
Latest about vaccines

HPV vaccine slashes cervical cancer rates by 87% among women in the UK
By Yasemin Saplakoglu published
The HPV vaccine reduced cases of cervical cancer by 87% among women in the U.K. who received the vaccine when they were 12 or 13 years old, according to a new study.

Should you mix and match COVID-19 vaccines?
By Yasemin Saplakoglu published
Many people will now be able to "mix and match" COVID-19 booster shots — that is, get a different COVID-19 vaccine for a booster, the FDA announced Wednesday (Oct. 20).

Which COVID-19 vaccine has the lowest rate of breakthrough infections?
By Nicoletta Lanese published
Hints in the data suggest the Johnson & Johnson vaccine has the most breakthroughs, while Moderna has the least.

Pfizer and Moderna vaccines may provide years of protection from COVID-19
By Yasemin Saplakoglu published
The mRNA vaccines will likely provide protection against the coronavirus for years if it doesn't evolve significantly, a small new study suggests.

Novavax's COVID-19 shots are 90% effective, company reports
By Nicoletta Lanese published
The shots are 100% effective against moderate and severe infections.

Should 12-year-olds get the COVID-19 vaccine?
By Ashley P. Taylor published
The benefits of vaccinating young people against COVID-19 outweigh the risks, experts say.

Is the COVID-19 vaccine causing rare myocarditis cases?
By Rachael Rettner published
Researchers in Israel say they've found a possible link between the Pfizer-BioNTech COVID-19 vaccine and cases of heart inflammation called myocarditis in young men.

Highly effective malaria vaccine could be a game-changer, early trial suggests
By Yasemin Saplakoglu published
A new malaria vaccine showed to be 77% effective in early clinical trials, the first to pass the World Health Organization's efficacy goal.
Get the world’s most fascinating discoveries delivered straight to your inbox.